Debra L. Richardson, Kathleen N. Moore, Kosei Hasegawa, Petar Jelinic, Connor Mailley, Sandra Re, Wanying Ma, Tsvetomir Mitov, Isabelle Laure Ray-Coquard. "REJOICE-Ovarian01: Phase 3 part of a phase 2/3 study evaluating raludotatug deruxtecan (R-DXd) versus treatment of physician’s choice in patients with platinum-resistant ovarian cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps5637